Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin —a post-hoc analysis of the UTOPIA study
ConclusionsThe beneficial effects of tofogliflozin on circulating levels of hepatic enzymes, uric acid, and Hb lasted for 2 years in patients with T2DM.Clinical trial registrationUMIN000017607 (https://www.umin.ac.jp/icdr/index.html)
Source: Diabetology International - Category: Endocrinology Source Type: research
More News: Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Liver | Obesity | Sodium | Study | Urology & Nephrology